Join the Spasticity group to help and get support from people like you.
Spasticity News (Page 2)
Multiple Sclerosis May Worsen With Menopause Transition
FRIDAY, Jan. 24, 2025 – The menopausal transition may represent an inflection point for worsening of multiple sclerosis (MS) in women, according to a study published online Dec. 23 in Neurology....
Pregnancy Increases Mental Health Risk in MS Patients
THURSDAY, Jan. 23, 2025 – Pregnancy increases the risk of mental illness among women with multiple sclerosis (MS). Pregnant MS patients have a higher risk of mental illness both during gestation and...
COVID-19 Doesn't Worsen Multiple Sclerosis, Study Says
FRIDAY, Dec. 27, 2024 – People with multiple sclerosis (MS) have been concerned that a COVID-19 infection could cause the symptoms of their nerve disease to become even worse. But a new study should...
Adverse Outcomes Seen With MS Disease-Modifying Drugs in Pregnancy
THURSDAY, Jan. 2, 2025 – Disease-modifying therapy (DMT) use for multiple sclerosis (MS) in pregnancy is associated with certain adverse outcomes, including small for gestational age, according to a...
Children Have Various Symptoms Within Five Years Before MS Diagnosis
FRIDAY, Dec. 27, 2024 – Children and adolescents with multiple sclerosis (MS) have a range of symptoms, signs, and diagnoses within five years before diagnosis, according to a study published online...
Certain Risk Factors for MS Linked to Pediatric Brain Volume
TUESDAY, Dec. 17, 2024 – Genetic and environmental risk factors for multiple sclerosis (MS) are associated with brain volume in childhood, according to a study published online Dec. 10 in the...
Parents' Smoking Could Raise Risk for MS in Kids
WEDNESDAY, Dec. 11, 2024 – For children genetically predisposed to develop multiple sclerosis (MS), exposure to cigarette smoke in the family home could raise that risk even higher, new research...
Social Determinants of Health Linked to Brain MRI Outcomes in Pediatric MS
MONDAY, Dec. 2, 2024 – For patients with pediatric-onset multiple sclerosis (POMS), social determinants of health (SDOH) are associated with worse brain magnetic resonance imaging (MRI) outcomes,...
Generic Medications Can Keep OOP Costs Down for Neurological Conditions
WEDNESDAY, Oct. 30, 2024 – Generic medications reduce the out-of-pocket (OOP) costs for common neurological conditions, apart from multiple sclerosis, for which costs continue to increase, according...
Cancer Incidence Increased for People With Multiple Sclerosis
WEDNESDAY, Oct. 9, 2024 – Cancer incidence is increased overall in people with multiple sclerosis (PwMS), with considerable differences depending on cancer type, age, and sex, according to a study...
European Committee for Treatment and Research in Multiple Sclerosis, Sept. 18-20
The annual Congress of the European Committee for Treatment and Research in Multiple Sclerosis was held from Sept. 18 to 20 in Copenhagen, Denmark, and drew more than 8,500 delegates from around the ...
Aggressive, Early Disease-Modifying Therapy May Slow MS Progression
FRIDAY, Sept. 27, 2024 – Reducing or preventing paramagnetic rim lesions (PRLs) could significantly slow multiple sclerosis (MS) progression, according to a study presented at the annual meeting of...
Anti-CD20 Therapy Shows No Effect on Disability Progression in MS
THURSDAY, Sept. 26, 2024 – For patients with primary progressive multiple sclerosis (PPMS), the time to confirmed disability progression (CDP) does not differ for those who are anti-CD20-treated and...
FDA Approves Injectable Ocrevus Zunovo for Relapsing, Progressive MS
THURSDAY, Sept. 26, 2024 – The U.S. Food and Drug Administration has approved Ocrevus Zunovo (ocrelizumab and hyaluronidase-ocsq) as the first and only twice-a-year, 10-minute subcutaneous injection...
Guidelines Provided for Diagnosis of Pediatric, Late-Onset Multiple Sclerosis
TUESDAY, Sept. 24, 2024 – In a clinical review conducted by an international committee of multiple sclerosis (MS) experts in pediatric and adult MS and published online Sept. 16 in JAMA Neurology,...